Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
4
×
Tags
celgene
4
×
biotech
bristol-myers squibb
life sciences
national blog main
deals
multiple sclerosis
national top stories
new york
new york blog main
new york top stories
novartis
ozanimod
acquisition
acquisitions
amgen
autoimmune diseases
bay city capital
bcma
biogen
bluebird bio
clinical trials
coronavirus
covid-19
crohn's disease
drug development
europe blog main
europe top stories
fda
fibrosis
fingolimod
ftc
galecto
giovanni caforio
glaxosmithkline
health/life sciences
idecabtagene vicleucel
interferon-beta
johnson & johnson
juno therapeutics
What
bristol
drug
4
×
myers
4
×
celgene
squibb
acquisition
delay
fda
multiple
acquire
amid
amira
approval
approved
approves
asks
bcma
bid
billion
biotech
came
candidate
cell
company’s
concerns
confidence
deal
declined
delayed
detour
divest
expect
experimental
fibrotic
ftc
galecto
group
hit
info
investors
Language
unset
Current search:
myers
×
celgene
×
drug
×
photo
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}